DiCE Molecules is a privately held biotechnology company bringing, for the first time, the power of directed evolution to the field of chemistry. Our first application of this technology is in the area of small molecule drug discovery.

DiCE was co-founded in 2013 by a highly experienced team including Pehr Harbury, Ph.D., investor of the core technology and pioneer of the field of directed evolution; Kevin Judice, Ph.D., a veteran chemist and biopharma executive; and Phil Patten, Ph.D., an expert in the field of directed evolution.